Tag: antiobesity market research

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Antiobesity Global Market Report 2024 Market from 2024 to 2033?

Similarly, the antiobesity market has also grown rapidly. It is expected to increase from $3.38 billion in 2023 to $3.76 billion in 2024, at a CAGR of 11.3%. Contributing to this growth are rising obesity rates, greater public awareness and education, lifestyle changes, and government initiatives.

The antiobesity market is set for rapid expansion, reaching $5.64 billion by 2028, growing at a CAGR of 10.7%. Factors driving this growth include market expansion and globalization. Major trends include research and development, patient-centric approaches, insurance coverage, technological advancements, digital health, novel drug therapies, and bariatric surgery advancements.

Claim Your Free Sample of the Global Antiobesity Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

What Key Factors Are Fueling the Growth of the Antiobesity Global Market Report 2024 Market?

Obesity is becoming a major global health concern, with the prevalence of obesity increasing every year. The World Obesity Atlas estimates that over 1 billion people worldwide will be obese by 2030. This rise is attributed to poor diets, sedentary lifestyles, and a lack of awareness about the health risks of obesity. Consequently, the demand for anti-obesity drugs is expected to grow, driving the market for obesity-related treatments.

What Are the Major Segments of the Antiobesity Global Market Report 2024 Market?

1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs

2) By Type: Prescription Drugs (Rx), OTC Drugs

3) By Medication: Monotherapies, Polytherapies

What New Trends Are Transforming the Antiobesity Global Market Report 2024 Market?

Companies in the anti-obesity drugs market are focusing on innovation with new products like Mounjaro (tirzepatide), aimed at helping individuals with obesity or weight-related health issues. Eli Lilly & Company launched Mounjaro in October 2022, which was FDA-approved and is used to treat obesity in adults, especially those with type 2 diabetes. This injectable medication, when combined with diet and exercise, helps manage blood sugar and promotes weight loss.

Order Now for Fast Delivery of Your Antiobesity Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

Which Regions Are Driving Growth in the Antiobesity Global Market Report 2024 Market?

North America was the largest region in the anti-obesity market in 2023. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Antiobesity Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the antiobesity global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Antiobesity Global Market Report 2024 Market Include

1. Antiobesity Global Market Report 2024 Market Executive Summary

2. Antiobesity Global Market Report 2024 Market Segments

3. Antiobesity Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Antiobesity Global Market Report 2024 Market Trends

5. Major Antiobesity Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Antiobesity Global Market Report 2024 Market

26. Top Antiobesity Global Market Report 2024 Companies

27. Antiobesity Global Market Report 2024 Market Opportunities And Strategies

28. Antiobesity Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Atorvastatin Global Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/atorvastatin-global-market-report

Low-Density Lipoprotein Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Liraglutide And Semaglutide Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liraglutide-and-semaglutide-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The anti-obesity market has witnessed substantial growth in recent years, and the trajectory remains upward. From $3.38 billion in 2023, the market is set to expand to $3.76 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 11.3%. The surge in the historic period is attributed to various factors like the increasing prevalence of obesity, heightened awareness and education, lifestyle shifts, and proactive government initiatives.

• Historic Growth Drivers:
  • Increasing Obesity Prevalence
  • Awareness and Education Initiatives
  • Lifestyle Changes
  • Government Initiatives

Anticipating Robust Growth
The forecast for the anti-obesity market is optimistic, projecting rapid growth in the coming years. By 2028, the market is expected to reach $5.64 billion, boasting a CAGR of 10.7%. The anticipated growth in the forecast period is attributed to several key factors.

• Forecasted Growth Factors:
  • Market Expansion
  • Globalization
• Major Trends in the Forecast Period:
  • Research and Development
  • Patient-Centric Approaches
  • Insurance Coverage
  • Technological Advancements
  • Digital Health and Telemedicine
  • Novel Drug Therapies
  • Bariatric Surgery Advancements
  • OTC (Over-the-Counter) Solutions
  • Behavioral Interventions
  • Nutritional and Weight Management Apps

Demographic Dynamics: Rising Geriatric Population
The growing geriatric population is poised to be a significant driver for the anti-obesity drugs market. Elderly individuals, aged 65 and older, often face challenges related to obesity due to reduced mobility and compromised blood circulation.

• Global Aging Scenario:
  • By 2030, 1 in 6 individuals globally will be 60 or older.
  • By 2050, there will be a doubling of individuals in this age group, reaching 2.1 billion.

Industry Giants: Key Market Players
Leading the charge in the anti-obesity market are major companies dedicated to research, development, and the delivery of effective solutions. These companies play a pivotal role in shaping the landscape of anti-obesity interventions.

• Key Market Players:
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Takeda Pharmaceutical Company Limited
  • Eisai Co. Ltd.
  • Novo Nordisk A/S
  • and many more.

View More On The Antiobesity Market Report 2024 – https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

Innovations at the Forefront: Product Innovations
In a quest to offer cutting-edge solutions, major companies operating in the anti-obesity drugs market are focusing on product innovations. One noteworthy example is the introduction of Mounjaro (tirzepatide) by Eli Lilly and Company.

• Mounjaro (tirzepatide):
  • FDA Approved Fast Track Designation
  • Injectable Form for Obesity and Type 2 Diabetes
  • Used to Achieve Weight Loss Goals

Market Segmentation: Understanding Diversity
The anti-obesity market is intricately segmented to cater to the diverse needs of end-users. Key segments include drug class, type, and medication.

• Market Segmentation:
  • Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs
  • Type: Prescription Drugs (Rx), OTC Drugs
  • Medication: Monotherapies, Polytherapies

Regional Dynamics: North America Leading the Way
In 2023, North America emerged as the largest region in the anti-obesity market. However, the Middle East is expected to take the lead in terms of growth, positioning itself as the fastest-growing region in the anti-obesity market.

In conclusion, the anti-obesity market showcases a robust growth trajectory driven by various factors, including demographic shifts, technological advancements, and the emergence of innovative therapies. As major players continue to invest in research and development, the landscape of anti-obesity interventions is set to evolve, offering promising solutions for individuals combating obesity globally.

Request A Sample Of The Global Antiobesity Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3403&type=smp